Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026 and Jun 2026.
- Largest single sale: $3.2M (53,447 shares) of Oruka Therapeutics, Inc. on May 21, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Director | Sep 6, 2024 | Jun 12, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 12, 2026, Oruka Therapeutics, Inc.: sold 12,583 shares for $882K, under a disclosed plan. 1 filing: 1
- Jun 11, 2026, Oruka Therapeutics, Inc.: sold 22,417 shares for $1.6M, under a disclosed plan. 1 filing: 1
- May 21, 2026, Oruka Therapeutics, Inc.: sold 105,000 shares for $6.2M, under a disclosed plan; 50,356 shares acquired by exercising options; 11,904 shares vested or acquired by exercising options. 1 filing: 1
- Jan 23, 2026, Oruka Therapeutics, Inc.: 116,483 shares in other transactions. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.